HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EXJADE safely and effect
![Effectiveness and tolerability of twice daily dosing of deferasirox in unresponsive and intolerant transfusion-dependent beta-thalassemia patients: A narrative review Effectiveness and tolerability of twice daily dosing of deferasirox in unresponsive and intolerant transfusion-dependent beta-thalassemia patients: A narrative review](https://ijp-online.com/articles/2020/52/6/images/Indian%20J%20Pharmacol_2020_52_6_514_309727_t2.jpg)
Effectiveness and tolerability of twice daily dosing of deferasirox in unresponsive and intolerant transfusion-dependent beta-thalassemia patients: A narrative review
![Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study - ScienceDirect Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1079979615300103-gr1.jpg)